HPO ID | HPO Term |
---|---|
HP:0007994 | Peripheral visual field loss |
HP:0007703 | Abnormality of retinal pigmentation |
HP:0001249 | Intellectual disability |
HP:0007843 | Attenuation of retinal blood vessels |
HP:0007675 | Progressive night blindness |
HP:0008046 | Abnormal retinal vascular morphology |
HP:0001513 | Obesity |
HP:0007737 | Bone spicule pigmentation of the retina |
HP:0000551 | Color vision defect |
Gene ID | Gene Symbol | Description |
---|---|---|
138050 | HGSNAT | heparan-alpha-glucosaminide N-acetyltransferase |
3419 | IDH3A | isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha |
3420 | IDH3B | isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta |
5158 | PDE6B | phosphodiesterase 6B |
55624 | POMGNT1 | protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) |
762 | CA4 | carbonic anhydrase 4 |
79947 | DHDDS | dehydrodolichyl diphosphate synthase subunit |
93589 | CACNA2D4 | calcium voltage-gated channel auxiliary subunit alpha2delta 4 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024